Finkelman R D, Linkhart T A, Mohan S, Lau K H, Baylink D J, Bell N H
Department of Periodontics, Loma Linda University, CA.
Proc Natl Acad Sci U S A. 1991 May 1;88(9):3657-60. doi: 10.1073/pnas.88.9.3657.
We demonstrated previously that implants of bone matrix prepared from vitamin D-deficient (-D) rats were less osteoinductive and contained less extractable mitogenic activity compared with control implants prepared from vitamin D-replete (+D) rats and proposed that bone from -D rats is deficient in one or more specific growth factors. To test this hypothesis, bones from rats that were fed either +D or -D diets and kept in the dark for 8 wk were extracted and assayed for insulin-like growth factors I and II (IGF-I and IGF-II) and transforming growth factor beta (TGF-beta), the three most abundant growth factors in rat bone, and osteocalcin. Serum calcium, 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] were determined at sacrifice. In -D rats, there were significant reductions in serum calcium, 25-hydroxyvitamin D3, and 1,25(OH)2D3 and skeletal TGF-beta but no differences in extractable skeletal protein, IGF-I, IGF-II, or osteocalcin compared with +D rats. To determine whether 1,25(OH)2D3 increased TGF-beta production by bone cells, we treated mouse calvaria for 6 days and mouse osteoblasts for 2 days with 10 nM 1,25(OH)2D3. Production of TGF-beta was increased almost 100% by 1,25(OH)2D3. We conclude that vitamin D deficiency reduces deposition of TGF-beta in rat bone and that diminished skeletal TGF-beta could contribute to the previously observed decrease in osteoinduction in implants from -D rat bone. The findings support the possibility that vitamin D and bone-derived TGF-beta are required for normal repair of the skeleton.
我们之前证明,与用维生素D充足(+D)大鼠制备的对照植入物相比,用维生素D缺乏(-D)大鼠制备的骨基质植入物的骨诱导性较低,且可提取的促有丝分裂活性较低。我们还提出,-D大鼠的骨中缺乏一种或多种特定生长因子。为了验证这一假设,我们提取了喂食+D或-D饮食并在黑暗中饲养8周的大鼠的骨骼,检测了胰岛素样生长因子I和II(IGF-I和IGF-II)、转化生长因子β(TGF-β)(大鼠骨中含量最丰富的三种生长因子)以及骨钙素。处死时测定血清钙、25-羟基维生素D3和1,25-二羟基维生素D3 [1,25(OH)2D3]。与+D大鼠相比,-D大鼠的血清钙、25-羟基维生素D3和1,25(OH)2D3以及骨骼TGF-β显著降低,但可提取的骨骼蛋白、IGF-I、IGF-II或骨钙素无差异。为了确定1,25(OH)2D3是否能增加骨细胞产生TGF-β,我们用10 nM 1,25(OH)2D3处理小鼠颅骨6天和小鼠成骨细胞2天。1,25(OH)2D3使TGF-β的产生增加了近100%。我们得出结论,维生素D缺乏会减少大鼠骨中TGF-β的沉积,而骨骼TGF-β的减少可能是之前观察到的-D大鼠骨植入物骨诱导性降低的原因。这些发现支持了维生素D和骨源性TGF-β是骨骼正常修复所必需的这一可能性。